Here are a few newsworthy items in the world of cancer research

• Vice President Joe Biden delivered his final “cancer moonshot” report on the promises and challenges in the fight against cancer.
• Scientist Pontus Nordenfelt at Lund University in Sweden has managed to describe and visualize cell migration on a molecular level. This could have an impact on the treatment of infectious diseases, inflammation, and cancer.  Further discussion in Nature Communications.
• Researchers at the University of Utah, Rutgers, and Temple recently announced results of a study that found  an association between socioeconomic status and risks of specific cancer types later in life. The results were published in Cancer Epidemiology, Biomarkers & Prevention.

Surfing the web, I uncovered these new items worth sharing:

• David J. Thouless, F. Duncan M. Haldane, and J. Michael Kosterlitz were awarded the Nobel Prize in Physics for discoveries in condensed-matter physics that have transformed the understanding of matter that assumes strange shapes.
• New research led by scientists from the University of New Mexico Comprehensive Cancer Center shows a reduction in cervical pre-cancers in young women who received the HPV vaccine. The results were published in JAMA Oncology.
• According to researchers at the University of Southern California, wearable technology may improve cancer treatment. This project will be presented at the White House as part of the Cancer Moonshot exhibit.  Read more about this project in ScienceDaily.
• Scientists are a step closer to developing an effective universal flu vaccine. The results have been published in PNAS.

Surfing the web, I uncovered these new items worth sharing:

• Researchers at Case Western Reserve University have developed a computer program to distinguish between radiation necrosis and recurrent brain cancer. In a comparison, the program outperformed a pair of neruoradiologists in diagnostic accuracy. Read more on this development in the American Journal of Neuroradiology.
• A new study outlines the development of a synthetic polymer capable of transporting a drug into lung cancer cells without affecting normal lung cells. The discovery that nanoparticles can be selective may have huge implications for patient outcomes.  The research has been published in PNAS.
• A new immunotherapy treatment has shown dramatic promise in treating patients with advanced pancreatic cancer. Patients enrolled in a trial receiving the new treatment, IMM-101 with chemotherapy, showed significant survival advantage compared to patients treated with only chemotherapy. Further details provided in the British Journal of Cancer.
• A recent study in the New England Journal of Medicine found that “active monitoring” of prostate cancer patients does not increase death rates as compared to patients that had undergone surgery or radiation.